Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Aritra Gangopadhyay

HISTORICAL FACTS: Insulet corporation earnings preview what to expect - The Untold Story

Acton, Massachusetts-based Insulet Corporation (PODD) develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company has a market cap of $13.4 billion and offers Omnipod platform products, including the Omnipod 5 automated insulin delivery system, Omnipod DASH insulin management system, and the Omnipod Insulin Management System.

PODD is expected to release its Q1 2026 earnings on Wednesday, May 6, before the market opens. Ahead of the event, analysts expect the company’s EPS to be $1.14 on a diluted basis, up 11.8% from $1.02 in the year-ago quarter. The company has exceeded Wall Street’s EPS estimates in each of its last four quarters.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.